Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis

We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Intern Med
Asıl Yazarlar: Nakamura, Masataka, Itani, Kumi, Miyake, Kousuke, Kunieda, Takenobu, Kaneko, Satoshi, Kusaka, Hirofumi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The Japanese Society of Internal Medicine 2017
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://ncbi.nlm.nih.gov/pubmed/28090055
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller